Updated:
NeoPro Nutritional Sciences
NeoPro Nutritional Sciences is a family office investing in nutritional sciences, targeting early-stage companies in dietary supplements and functional...
NeoPro Nutritional Sciences
NeoPro Nutritional Sciences is a family office that invests in the nutritional sciences sector, with a focus on early-stage companies and technologies. The firm's founding and wealth origin remain undisclosed, but its name suggests a tie to the nutritional supplements or functional foods industry. The firm targets investments in dietary supplements, functional foods, and related biotechnology. Known interests include companies developing science-backed nutritional products and technologies that enhance human health (per public record). The investment stage is typically early-stage, with a preference for direct equity stakes and co-investments alongside other family offices. No team size or additional offices have been publicly reported. The firm's deployment scale and AUM are not disclosed. Based on its sector focus and structure, NeoPro likely operates with a small, dedicated team and a single office. A distinct structural feature is the firm's tight sector focus on nutritional sciences, a niche within the broader health and wellness ecosystem. This specialization suggests deep domain expertise and a network concentrated in that industry, though the firm's governance and succession plans remain opaque.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
United States
Corporate office
United States
Sector focus
Frequently asked questions
What sectors does NeoPro Nutritional Sciences target?
NeoPro Nutritional Sciences focuses on the nutritional sciences sector, including dietary supplements, functional foods, and related biotechnology. The firm seeks opportunities in science-backed nutritional products and technologies (per public record).
Is NeoPro a single family office or a multi-family office?
Public records indicate NeoPro Nutritional Sciences operates as a single family office, managing the capital of one family with a mandate focused on nutritional sciences. The structure suggests a long-term, patient capital approach typical of family offices.
Does NeoPro participate in fund commitments or only direct deals?
Based on available information, NeoPro Nutritional Sciences appears to favor direct investments and co-investments in early-stage nutritional sciences companies. There is no public evidence of fund commitments.
Where does the underlying wealth originate?
The origin of wealth for NeoPro Nutritional Sciences is not publicly disclosed. The firm's name and focus may indicate wealth derived from the nutritional supplements or functional foods industry, but this is speculative.
What investment stages does NeoPro typically target?
NeoPro Nutritional Sciences targets early-stage companies, including venture-stage and growth-stage nutritional sciences firms. The firm's deal focus is on direct equity stakes.
How does NeoPro source its deal flow?
Deal sourcing at NeoPro is likely driven by the family's network in the nutritional sciences industry, including relationships with researchers, entrepreneurs, and other family offices. No formal sourcing mechanism is disclosed.
Is NeoPro's team known publicly?
No principals or team members for NeoPro Nutritional Sciences have been publicly identified. The firm maintains a low profile, typical of many single family offices, and does not disclose its investment team.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: